Trial Profile
An open-label, randomized, parallel group study to compare the changes in asthma control variables by budesonide vs. budesonide/formoterol in mild to moderate asthmatic patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Budesonide (Primary) ; Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
- 06 Mar 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 07 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.